GleamWall
中文EN

KBLB Kraig Biocraft Laboratories, Inc.

Plastic Material, Synth Resin/Rubber, Cellulos (No Glass) · OTC · SEC CIK 1413119 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-5.3%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-127.4%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets300.7%
Debt / equity—
Current ratio0.27x
Interest coverage-5.67x

Cash quality & payout

Operating cash flow / net income0.56x
Accruals ratio-56.2%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue——
R&D expense$165,758$164,374
SG&A expense$1.96M$1.75M
Operating income-$3.37M-$3.07M
Interest expense$570,709$529,603
Pretax income-$3.62M-$3.40M
Net income-$3.62M-$3.40M
EBITDA-$3.35M-$3.05M
EPS (basic)0.000.00
EPS (diluted)0.000.00
Weighted avg. shares (diluted)1.06B1.04B
Balance sheet
Cash & equivalents$1.79M$673,264
Short-term investments$0$0
Inventory$29,067$6,884
Current assets$1.87M$740,285
PP&E, net$25,003$44,721
Total assets$2.57M$1.51M
Current liabilities$10.45M$9.61M
Total liabilities$10.56M$9.65M
Shareholders' equity-$8.00M-$8.15M
Cash flow statement
Operating cash flow-$1.79M-$1.84M
Capital expenditure$5,395$4,240
Free cash flow-$1.79M-$1.84M
Investing cash flow$438,042-$4,240
Financing cash flow$2.47M-$35,244
Depreciation & amortization$25,113$26,159
Stock-based compensation$87,285—

Free plan shows the latest 2 periods; Pro shows all 19 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.